@article{article_123209, title={Middle East Respiratory Syndrome: MERS}, journal={Journal of Microbiology and Infectious Diseases}, volume={5}, pages={93–98}, year={2015}, DOI={10.5799/ahinjs.02.2015.02.0184}, author={Parlak, Emine}, keywords={Coronavirus, Middle East Respiratory Syndrome, MERS-CoV polymerase-chain-reaction, respiratory symptoms}, abstract={<p> <span>Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging respiratory virus. It was first identified in Saudi Arabia in 2012. MERS-CoV infection is characterized by a spectrum of illness ranging from mild to acute and fulminant disease. The majority of patients present with fever, fever with chills/rigors, cough, shortness of breath, and dry cough. Cases of human-to-human transmission have been documented. There is currently no specific treatment and vaccination for MERS-CoV infection. Surveillance and infection-control measures are of vital importance to an ef­ficient public health response.  </span> <em>J Microbiol Infect Dis 2015;5(2): 93-98 </em> </p> <p> <strong>Key words: </strong> Coronavirus, Middle East Respiratory Syndrome, MERS-CoV polymerase-chain-reaction, respiratory symptoms </p>}, number={2}, publisher={Aydın ECE}